ClinicalTrials.gov
public full text
Public Domain
Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children
The purpose of this study is to determine if amphotericin B is effective against visceral leishmaniasis in Brazilian children. Amphotericin B will be compared to meglumine antimoniate which is the current approved drug used for this disease in Brazil.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Avaliação do potencial de peptídeos sintéticos de Leishmania infantum para o diagnóstico da Leishmaniose visceral canina.#1225740
- Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly#1096180
- Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis#261306
- Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar#853320
- Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis#127716
Record · ID 1185148
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive